Strategies for Penny Stock

Penny stock trading can provide opportunities for 100% or greater returns, often happening in days not years.  Many think that picking  gem stock requires extreme skill.  They are right to some extend.  The right piece of information together will skill makes the right ingradiant for picking  the winner.  Our Penny Stock tips will help you maximize the profit in trading. A lots of money is to be made in trading penny stock. 

Buy them before promoting. The best way to invest in penny stocks is by buying them before they are heavily promoted and hyped up in price.  Heavy promotional campaigns are important to penny stocks. Penny stocks are typically not covered by analyst. As a result, penny stock companies have to rely on heavy promotional campaigns to get the word out about their stock. If you get into the stock at the early phase of that promotional campaign, you could make a fortune.

Many penny stock will explode with in  few months of promoting.  If you check the history of penny stocks, you will find that most of them were trading at a decent price 15months before. However hard the market slams a stock, there’s always a chance the company will address its problems, perceptions will change and its share price will come storming back.

Buy the stock at low prices and wait for the price to rise so you can cash out big. Remember for  every stock, you should have an exit strategy.

Posted in Investing, Penny Stock | Tagged , , , | 2 Comments

Investing in Biotech Stocks

Biotech is always an exciting sector for market players to invest in. In Biotech stock, risk is high but the returns are also sweet. Generally Biotech  firms are struggling to stay in business as research and developments costs eat through their cash positions.

Unfortunately, the only way that biotech companies have a chance at coming to market with a successful drug is by spending money on R&D.  Every Biotech or pharmacy company has to pass many hurdles before they come up with a successful product in the market. If you take the history of Biotech companies, most of them had been at the brink of Bankruptcy at one point of their life.  This is primarily due to the lack of income during the research and development stage of the product. It takes long to successfully develop, get approved by FDA and successfully market the product.  Check to see whether they have enough money to survive through this phase.

 A good way to gauge how well a biotech company is doing is to simply follow the FDA trials for its key drugs. If you follow the trials, you can see if any potential drug is advancing or showing positive results. Of course, these trials make for great catalysts for the stocks, especially when there is bullish news.

Keep watch on companies coming up on trials for phase II and phase III studies of FDA drug approval. Combine that key information with an unemotional view of a potential company’s stock chart, and you might be able to spot some big opportunities in the biotech sector.

There are a number of companies poised to report key clinical results, it might be well worth the time to evaluate their charts. So watch out for FDA announcements.

Posted in Biotech Stock, Investing | Tagged , , | 16 Comments

Obama Signs Credit Card Reforms

U.S. President Barak Obama has signed sweeping credit card reforms into law. The reforms are designed to protect cardholders from certain interest rate hikes, unfair fees, issuing, and billing practices, and generally require greater transparency and accountability from card issuers. While most consumer rights groups applaud the reforms as long overdue restrictions on deceptive and predatory practices, some serious points of concern were raised this week in the econo-blogosphere.

This legislation will significantly change the way credit card companies conduct business… consumers will see smaller credit lines, higher interest rates, higher membership fees, and fewer 0 percent offers.  Rewards offers will likely stay the same… While the effects of the legislation… may seem wholly negative, the long-term effects will result in a net benefit for consumers.

There’s a good reason for credit card companies to want lots of users who aren’t very profitable. Imagine a world in which 42 percent of households pay their bills and 58 percent miss the occasional payment. Now imagine that the credit card companies lose a bit of money on the 42 percent and make a lot of money on the 58 percent. They still need that 42 percent. The credit industry works best when everyone has a credit card. That only happens when most places take credit cards. And that requires not only huge volume, but also credit card penetration across different segments of society. Credit cards have to be the norm everywhere if everyone is going to have credit cards and that 58 percent is going to contain the maximum number of people.

Posted in Credit Card | Tagged , , , | 9 Comments

Intellicheck Mobilisa CEO Video

Intellicheck Mobilisa CEO Video:  Intelli-Check Mobilisa, Inc. develops and markets wireless technology and identity systems for mobile and handheld wireless devices for the government, military, and commercial markets.  The company was founded in 1994 and is headquartered in Port Townsend, Washington.  The companyfs products are used to address government and commercial fraud, focusing on age verification, secure access control and software tools, driversf license readers, and ID validation markets. The company is traded under thwe symbol IDN at AMEX.

Posted in Investing, Penny Stock | Tagged | Leave a comment

Getting out of Credit Card Debt

Credit card debt is a plague and one should try to get out of it ASAP.  Unfortunately for most of them it is hard to pay off the credit card debts immediately.  Often one will not have the resources to pay of the loans.  The immediate focus has to be on getting out of debt, provided you have the emergency fund to last for 9 to 12 months. 

Emergency Fund: Having an emergency savings fund is even more important than being debt-free. “The sad reality is that the credit card industry is taking actions to protect themselves with no regard to your needs or how good you have been in paying your bills on time,” she said, referring to the fact that credit card companies have been lowering credit limits, increasing interest rates, and revoking credit cards altogether.  This means that many could find themselves without any access to credit following a job loss, when they need it most.  Imagine you are out of work and have no credit card,  you won’t be able to support yourself in this situation.   That is where emergency find becomes critical.   So top up your emergency fund before paying of the credit card in full.

First pay of the cards which is having more interest rate.  In this way, you can prevent paying high interest.

Posted in Credit Card | Tagged , , , | 2 Comments

Benefits of Investing In Biotechnology

World has been looking since ages to find newer cures and bring about a marked advancement in the filed of medical applications. In the last few years, biotechnology has contributed significantly towards this field.

There have been significant developments in biotechnology making it one of the most lucrative investment options. Yes, biotechnology investing is considered to be the future by many investment experts.

Most venture capitalists today are looking at biotechnology companies in a different light. The opportunities for investors to generate impressive revenue growth are one of the prime reasons why this has happened.

Also the trend to spend till we get the best in health care is another reason. Man does not like to compromise when it comes to good health and biotechnology has been one of the chief gainers of this principle.

Why is it Important to Invest in  Biotech?

There are many small biotech companies who are waiting for that golden opportunity. Some of these companies have displayed their flair and skill in just a few years of their existence.

With the right investors these companies can work wonders. Who knows, the drug for Alzheimer’s or cancer might just be underway in some of these companies.

From a business point of view, such a drug can be the single factor that will power you from rags to riches.

But biotechnology investing is not that easy. It is a task that requires a set of special skills so that you can spot the best company instantly.

Finding the right company to invest

It is very hard for the novice investor to follow up the Biotech stocks.  The best option in this case is to follow reputed stock analyst or invest in Biotech Based mutual funds.

Posted in Biotech Stock, Investing | Tagged , , | 2 Comments

Investing Basics

How do we decide to invest in a particular stock? We will examine steps in selecting the stocks. PE ratio of a share tells you how many rupees you have to pay for every rupee worth of net profit of the company.

Thus, if a company has one crore shares and a net profit of Rs 100 crore, each share commands a profit of Rs 100. If you have to pay Rs 200 per share, the PE ratio is 2. In other words, for every two rupees you invest, your effective return is one rupee per year.

Of course, you might actually get in hand only a part of this since only the part of profits that is distributed as dividends is handed over to the investor, but even the rest is reinvested in the company, thus adding to the value of your share. It should be clear that this is a fantastic rate of return, considering that to earn one rupee a year from a bank fixed deposit you would need to invest about Rs 10.

Today, share prices have fallen so much that in many cases, the PE ratio is down to 2 or even lower. That means if you are investing Rs 100 to buy a share of such a company, your investment will earn Rs 50 or even more in one year.

For those who are skeptical about whether the reinvested portion of profits really helps them, here’s the opinion of Warren Buffet, one of the world’s richest men and widely regarded as among the most savvy investors.

Buffett believes companies that reinvest the entire amount back are a better bet to put your money in. He has argued that you buy a share because it gives you betters return than investment in other instruments.

If a company is growing, it will need to invest in the future and hence distribute little or nothing as dividend. Such a company is actually enhancing your returns for the future.

On the other hand, a company that gives back the entire earning in the form of dividend is effectively telling you it cannot find anything to do with the money, which means it is unlikely to grow and hence likely to yield low returns in future.

On average, good companies with a healthy future tend to earn returns of around 20% on their total investment as against a return on bank deposits of around 10%. In normal times, PE ratios of blue chip companies would of the order of 20, though in cases where future earnings are expected to be much higher you could have correspondingly higher PE. (Of course, it varies from industry to industry, which is why it makes more sense to compare PEs of companies within a certain industry rather than across industries.)

That brings us back to the abnormally low PE ratios for several blue chips in the Indian market today (see chart). Take the example of Hindalco Industries. Its annualized net profit on the basis of its first quarter result for 2008-09 would be Rs 2,787 crore. It has 122.65 crore shares. Therefore, every share of the company has an underlying profit Rs 22.64. But a Hindalco share could be bought on Monday for just Rs 40.40. That means, an investment of Rs 40.40 could earn a net profit of Rs 22.64 in one year, a PE ratio of 1.78. That’s an annual rate of return of over 56%.

Similarly, Tata Steel’s PE ratio of 2.11 at Monday’s closing price means buying the share gives you an annualized return of over 47%. Including
these two, there are at the moment seven scrips out of the 30 in the sensex that are trading at PE multiples of less than 5. In other words, the underlying return on investments in these scrips would be over 20% per annum.

Of course, there is a caveat to be added here. These calculations are all assuming that results declared so far are a good indicator of annualized earnings. If earnings in the remaining quarters do not match up to what was achieved in the first quarter, then PE multiples would be higher even at the same share prices.

Even if the PE multiples rise to say 10, it would make sense to invest provided the company is growing in the long run. After all, when you invest in equity you are looking not only at returns from earnings, but also at potential capital appreciation.

Posted in Investing | Tagged , , | 14 Comments